Main > NEUROLOGY. > Multiple Sclerosis > Treatment > AlemtuzuMAb (Anti CD52 MAb) > Co.: USA. G. (Phase III/Patent) > Patent>Assignee; Claims; No.; Etc.

---

This data is not available for free


Patent>Assignee; Claims; No.; Etc.'s products
This section has no products